Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s539, 2025. DOI: 10.25251/skin.10.supp.539. Disponível em: https://skin.dermsquared.com/skin/article/view/3323. Acesso em: 20 may. 2025.